New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.

AI hallucination is often misread as creativity. This explains why it’s a symptom of optimization fatigue, and what that ...

A new study by Scripps Research reveals that alcohol dependence disrupts two signaling pathways in a stress-related part of ...

A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound ...